Clinical Trial Update: Study to Evaluate the Efficacy of Afatinib in Skull Base Chordoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating the efficacy of afatinib in chordoma of the clivus is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma of the Clivus

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Huashan Hospital | Conditions: Chordoma of Clivus | Phase 2 | Status: UNKNOWN